<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H0C29032D62CD42EFAC4F04AA61C6C871" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2372 IH: Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2372</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250326">March 26, 2025</action-date><action-desc><sponsor name-id="L000582">Mr. Lieu</sponsor> (for himself, <cosponsor name-id="C001080">Ms. Chu</cosponsor>, and <cosponsor name-id="N000147">Ms. Norton</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to enhance medical device communications and ensure device cleanliness.</official-title></form><legis-body id="H4E0B2511AE804090A28140B69D2F3A42" style="OLC"> 
<section id="H1D56D62A52EB47AB9C726D80E8DCDD66" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2025</short-title></quote> or the <quote><short-title>DEVICE Act of 2025</short-title></quote>.</text></section> <section id="H4399D7AFF915425998202A3678AA3F0B"><enum>2.</enum><header>Reporting requirement for design and reprocessing instruction changes</header> <subsection id="HE9295BCE7B31444EB99A9DEC5DFA108C"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>) is amended by inserting after paragraph (j) the following:</text> 
<quoted-block display-inline="no-display-inline" id="H92BDABA209984D50B0D6024610953DDC" style="OLC"> 
<subsection id="H178362DB2D674CD2AD2ACB4755B43AA4"><enum>(k)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(r) (relating to design and reprocessing changes).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="H129908046CA14B88BFBB11ACC14CE925"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>) is amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="H565A806A9ACB419D9D763B29585627EC" style="OLC"> 
<subsection id="HBC21B6CAADFB40A9BE46C87E2B8B7039"><enum>(r)</enum><header>Reporting requirement for device design changes</header><text display-inline="yes-display-inline">Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Secretary.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> <section id="HDC314CE965B24F6F87189B4F9AE50778"><enum>3.</enum><header>Reporting requirement for certain communications to foreign health care providers</header> <subsection id="H251DB82796084C5093A1F5CA68A7F860"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>), as amended by section 2 of this Act, is further amended by inserting after paragraph (k) the following:</text> 
<quoted-block display-inline="no-display-inline" id="HE08C3436924D441387515846BF38A62D" style="OLC"> 
<subsection id="H749EC86D0E7A448D8389805CB2978823"><enum>(l)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(s) (relating to communications to foreign health care providers).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection> <subsection id="H007CFBBB34C64108B5A9BDC9B7ECB979"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by section 2 of this Act, is further amended by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="HD2F71DEA3F024E4699EB5CF1F08555C6" style="OLC"> 
<subsection id="H7AD4120B42F24C128891679BC9CEF2B3"><enum>(s)</enum><header>Reporting requirement for certain communications to foreign health care providers</header> 
<paragraph id="H85DFFADDD6BA402B815019CDC797A675"><enum>(1)</enum><header>Requirement</header><text display-inline="yes-display-inline">The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Secretary of any communication described in paragraph (2) not more than 5 calendar days after making such communication.</text></paragraph> <paragraph id="H018A135B3D94421D8F6B30BACBA11658"><enum>(2)</enum><header>Communication described</header><text>A communication is described in this paragraph if the communication—</text> 
<subparagraph id="HF964E18FAD264F4EB28C0C2FE01BCAB9"><enum>(A)</enum><text>is made by the manufacturer of the device or an affiliate of the manufacturer;</text></subparagraph> <subparagraph id="H13E135E6F84743A9A332BC7DBE2B1594"><enum>(B)</enum><text>relates to a change to the design of the device, a change to the recommended reprocessing protocols, if any, for the device, or a safety concern about the device; and</text></subparagraph> 
<subparagraph id="HA26C1DF508B146499EF4BDB27FC09A4B"><enum>(C)</enum><text>is widely disseminated (including on a voluntary basis) to health care providers in a foreign country.</text></subparagraph></paragraph> <paragraph id="HFBB39F4A636344248901E3C80B75C84E"><enum>(3)</enum><header>Affiliate</header><text display-inline="yes-display-inline">In this subsection, the term <term>affiliate</term> means a business entity that has a relationship with a second business entity if, directly or indirectly—</text> 
<subparagraph id="H7F5812F8CE09454E8722531FE92A9976"><enum>(A)</enum><text>one business entity controls, or has the power to control, the other business entity; or</text></subparagraph> <subparagraph id="HA4A95430B2864015AF0C1CEC735A1F56"><enum>(B)</enum><text>a third party controls, or has the power to control, both of the business entities.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> 
<section id="H8B543104610B4DA4904E489FB7A39489"><enum>4.</enum><header>Rapid assessment tests intended to ensure proper reprocessing</header> 
<subsection id="HF37F8EF5B0DD4BC7AAED4C6A48053BA2" commented="no"><enum>(a)</enum><header>Inclusion in device definition</header><text display-inline="yes-display-inline">Section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>) is amended—</text> <paragraph id="HA111638E50CA49F68926FCCCF87665AE" commented="no"><enum>(1)</enum><text>in paragraph (h)(1)—</text> 
<subparagraph id="HD561E5AA02B04577A32CEE17D358B171" commented="no"><enum>(A)</enum><text>in clause (B), by striking <quote>or</quote> at the end;</text></subparagraph> <subparagraph id="HC9D79476EBE44BC9A26B45A64B52CA3F" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">in clause (C), by striking <quote>and</quote> at the end and inserting <quote>or</quote>; and</text></subparagraph> 
<subparagraph id="HC80956312305448BBDD57FD65D9178C8" commented="no"><enum>(C)</enum><text display-inline="yes-display-inline">by inserting after clause (C) the following:</text> <quoted-block display-inline="no-display-inline" id="H77CB039E892D47389A56FAC0D21C34E4" style="OLC"> <subparagraph id="HD1FB315E51B047EFAE3BB74F04BAD9B5" commented="no" indent="up2"><enum>(D)</enum><text display-inline="yes-display-inline">a rapid assessment test intended to ensure the proper reprocessing of a reusable device (as defined in paragraph (tt)), and</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph id="H922BF4C2A81B4314AF04A82DCF8B5AD9" commented="no"><enum>(2)</enum><text>by adding at the end the following:</text> <quoted-block display-inline="no-display-inline" id="HD06C251BD9FD45D8B4603F9EC8409671" style="OLC"> <subsection id="H04A43F1E493D45EA803E1EB30AE5863F" commented="no"><enum>(tt)</enum><text display-inline="yes-display-inline">The term <term>reusable device</term> means a device that—</text> 
<paragraph id="H97A753C992AC4832B04BC249025E9CB5" commented="no"><enum>(1)</enum><text>is intended to be used more than one time; and</text></paragraph> <paragraph id="HD0D7C791291B436386AB0A8E0854A87E" commented="no"><enum>(2)</enum><text display-inline="yes-display-inline">must be sanitized (whether through cleaning, disinfection, or sterilization) to ensure that the device is safe and effective for such intended use.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> 
<subsection id="H7FD1021EE7144776BA20A766B924CC40"><enum>(b)</enum><header>Instructions for use and validation data</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by sections 2 and 3 of this Act, is further amended by adding at the end the following:</text> <quoted-block display-inline="no-display-inline" id="H62BD24E304B3467682A452DE83BD098C" style="OLC"> <subsection id="HAF26172F64664631BD15139A31F417E6"><enum>(t)</enum><header>Instructions for use and validation data</header> <paragraph id="H304B4EF3806C4877B041C9458D6BE3EA"><enum>(1)</enum><header>Initial list</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this subsection, the Secretary shall by regulation develop and publish a list of types of rapid assessment tests described in section 201(h)(1)(D) for which reports under subsection (k) must include—</text> 
<subparagraph id="HC83EB615714147A3B741460244B1AE99"><enum>(A)</enum><text>instructions for use that have been validated in a manner specified by the Secretary; and</text></subparagraph> <subparagraph id="H16A3E92B5A8945D08D418AA37FEB525D"><enum>(B)</enum><text>validation data, of the types specified by the Secretary.</text></subparagraph></paragraph> 
<paragraph id="HD6DCD2E31A8A4FB8BD1E676E527D9F72"><enum>(2)</enum><header>Updates</header><text display-inline="yes-display-inline">The Secretary shall by regulation periodically update the list required by paragraph (1).</text></paragraph> <paragraph id="HB32A4C6AA3F845FB86122BB06C492C06"><enum>(3)</enum><header>Enforcement</header><text>Beginning on the date of publication of the initial list under paragraph (1), the Secretary shall not accept any notification under subsection (k) for clearance of a type of rapid assessment test that is included on such list unless such notification includes instructions for use and validation data in accordance with paragraph (1).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section> 
</legis-body></bill>

